We are live on ! Find out more
SCM

Sio Capital Management Portfolio holdings

AUM $604M
1-Year Est. Return 96.57%
This Fund
S&P 500
This Quarter Est. Return
-12.6%
1 Year Est. Return
+96.57%
3 Year Est. Return
+564.25%
5 Year Est. Return
+486.18%
10 Year Est. Return
+2,856.71%
AUM
$323M
AUM Growth
-$70.1M
Cap. Flow
+$98.2M
Cap. Flow %
30.39%
Top 10 Hldgs %
57.75%
Holding
64
New
17
Increased
10
Reduced
12
Closed
12

Top Buys

Rank Stock Value
1
GMED icon
Globus Medical
GMED
+$17M
2
PFE icon
Pfizer
PFE
+$15.9M
3
TFX icon
Teleflex
TFX
+$14.6M
4
TVTX icon
Travere Therapeutics
TVTX
+$12.5M
5
REGN icon
Regeneron Pharmaceuticals
REGN
+$12M

Top Sells

Rank Stock Value
1
GEHC icon
GE HealthCare
GEHC
+$26M
2
CI icon
Cigna
CI
+$15.5M
3
AXNX
Axonics, Inc. Common Stock
AXNX
+$8.28M
4
PDCO
Patterson Companies, Inc.
PDCO
+$8.15M
5
HUM icon
Humana
HUM
+$5.81M

Sector Composition

Rank Sector Weight
1 Healthcare 99.97%
2 Miscellaneous 0.03%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
LH icon
1
Labcorp
LH
$27.2B
$33.9M 10.5%
168,809
+3,630
+2% +$766K
GMED icon
2
Globus Medical
GMED
$11.1B
$25.7M 7.94%
516,981
+304,388
+143% +$17M
GSK icon
3
GSK
GSK
$102B
$18.5M 5.71%
509,000
+29,468
+6% +$1.05M
UTHR icon
4
United Therapeutics
UTHR
$22.1B
$18.4M 5.71%
81,606
+1,680
+2% +$387K
CI icon
5
Cigna
CI
$73.7B
$16.7M 5.16%
58,226
-54,448
-48% -$15.5M
GEHC icon
6
GE HealthCare
GEHC
$32.4B
$16.5M 5.1%
242,308
-357,500
-60% -$26M
BCYC
7
Bicycle Therapeutics
BCYC
$294M
$16M 4.96%
796,933
-171,738
-18% -$3.93M
PFE icon
8
Pfizer
PFE
$159B
$14.9M 4.63%
+450,700
New +$15.9M
OGN icon
9
Organon & Co
OGN
$3.61B
$13.3M 4.12%
767,000
+362,062
+89% +$7.55M
TFX icon
10
Teleflex
TFX
$5.92B
$12.7M 3.92%
+64,491
New +$14.6M
REGN icon
11
Regeneron Pharmaceuticals
REGN
$81.8B
$12.6M 3.88%
+15,250
New +$12M
MDT icon
12
Medtronic
MDT
$117B
$8.68M 2.69%
+110,780
New +$9.27M
EMBC icon
13
Embecta
EMBC
$286M
$8.55M 2.65%
+568,294
New +$10.7M
HCSG icon
14
Healthcare Services Group
HCSG
$1.54B
$8.45M 2.62%
+810,307
New +$10.1M
OFIX icon
15
Orthofix Medical
OFIX
$395M
$8.36M 2.59%
+650,000
New +$11.7M
ZBH icon
16
Zimmer Biomet
ZBH
$19.2B
$8.24M 2.55%
+73,400
New +$9.32M
TVTX icon
17
Travere Therapeutics
TVTX
$6.19B
$7.91M 2.45%
+884,770
New +$12.5M
VKTX icon
18
Viking Therapeutics
VKTX
$3.75B
$6.59M 2.04%
595,002
+67,345
+13% +$963K
GRCL
19
DELISTED
Gracell Biotechnologies Inc. American Depositary Shares
GRCL
$5.99M 1.86%
+2,081,216
New +$7.61M
BBIO icon
20
BridgeBio Pharma
BBIO
$15B
$5.88M 1.82%
+222,947
New +$6.33M
CNTA
21
DELISTED
Centessa Pharmaceuticals
CNTA
$4.9M 1.52%
756,891
-120,302
-14% -$823K
SPRY icon
22
ARS Pharmaceuticals
SPRY
$586M
$4.18M 1.29%
1,105,911
+563,335
+104% +$3.7M
PTGX icon
23
Protagonist Therapeutics
PTGX
$9.34B
$4.14M 1.28%
+248,127
New +$4.81M
KRTX
24
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
$4.08M 1.26%
+24,129
New +$4.54M
RVNC
25
DELISTED
Revance Therapeutics, Inc.
RVNC
$3.93M 1.22%
342,477
+200,977
+142% +$3.86M
1
2 3

Similar funds

EFL
ERn Financial LLC Middleton, Wisconsin $604M AUM 19.83% 1-Year Est. Return
V
VeraBank Henderson, Texas $604M AUM 23.32% 1-Year Est. Return
MAM
Morse Asset Management Darien, Connecticut $604M AUM 72.61% 1-Year Est. Return
RCM
Requisite Capital Management Dallas, Texas $605M AUM 17.2% 1-Year Est. Return
AMG
Advisors Management Group La Crosse, Wisconsin $604M AUM 64.38% 1-Year Est. Return
VV
Verbena Value Westport, Connecticut $605M AUM
VCP
Varenne Capital Partners Paris, France $603M AUM 46.34% 1-Year Est. Return
EHI
Eagle Health Investments Greenwich, Connecticut $603M AUM 111.06% 1-Year Est. Return

Sio Capital Management's Q3 2023 Portfolio in Review

As of Q3 2023, Sio Capital Management held 64 positions worth $323M, down 18% from $393M the previous quarter. Its ten largest holdings account for 58% of the portfolio.

Sio Capital Management deployed $98.2M of net new capital in Q3 2023, opening 17 new positions and adding to 10 existing holdings. Its largest new stake was Pfizer: 450,700 shares worth $14.9M.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, up from 72% a quarter earlier, followed by Miscellaneous.

On the sell side, the largest reduction was GE HealthCare, an estimated $26M trimmed.

  • Sio Capital Management's largest Q3 2023 buy was Pfizer: 450,700 shares worth $14.9M.
  • Sio Capital Management added most to Globus Medical in Q3 2023, an estimated $17M increase.
  • Sio Capital Management's biggest Q3 2023 reduction was GE HealthCare, cutting an estimated $26M.
  • Sio Capital Management fully exited Axonics, Inc. Common Stock in Q3 2023, selling an estimated $8.28M.
  • Sio Capital Management's ten largest holdings make up 58% of its $323M portfolio in Q3 2023.
  • Sio Capital Management opened 17 new positions and closed 12 in Q3 2023.
  • Sio Capital Management's portfolio value fell 18% quarter-over-quarter to $323M.

Based on Sio Capital Management's 13F filing for Q3 2023, filed 14 Nov 2023.